LPL Financial Portfolio holdings
LPL Financial, founded in 1989 through the merger of Linsco and Private Ledger and headquartered in San Diego, California, is the largest independent broker-dealer in the U.S., supporting over 22,000 financial advisors who manage more than $1.4 trillion in advisory and brokerage assets as of late 2024. Serving independent advisors, banks, and credit unions, LPL provides a robust technology platform, research, and back-office support, enabling advisors to offer personalized wealth management, retirement planning, and investment services to clients without proprietary products. The firm, publicly traded since 2010 under CEO Dan Arnold, has grown through acquisitions like Waddell & Reed’s wealth management business in 2021, emphasizing flexibility and advisor autonomy. With additional offices in Fort Mill, South Carolina, and Boston, LPL Financial remains a leader in empowering advisors amid a shifting financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Growth ETF
IVW
|
+$346M |
| 2 |
Apple
AAPL
|
+$225M |
| 3 |
iShares MSCI EAFE Growth ETF
EFG
|
+$223M |
| 4 |
Microsoft
MSFT
|
+$217M |
| 5 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$181M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE Value ETF
EFV
|
+$124M |
| 2 |
Vanguard Total Bond Market
BND
|
+$66.2M |
| 3 |
iShares ESG Aware MSCI USA ETF
ESGU
|
+$64.2M |
| 4 |
iShares Global Energy ETF
IXC
|
+$62.3M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$60.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.15% |
| 2 | Financials | 3.16% |
| 3 | Healthcare | 2.8% |
| 4 | Consumer Discretionary | 2.64% |
| 5 | Industrials | 2.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4726
Newmark Group
NMRK
$2.65B
| $108K | ﹤0.01% |
10,580
-16,246
| -61% | -$165K |
|
4727
FinWise Bancorp
FINW
$192M
| $108K | ﹤0.01% |
10,595
-1,500
| -12% | -$15.4K |
|
4728
Taysha Gene Therapies
TSHA
$1.61B
| $108K | ﹤0.01% |
48,060
+5,998
| +14% | +$17.5K |
|
4729
Genelux
GNLX
$126M
| $108K | ﹤0.01% |
55,177
+9,215
| +20% | +$31.3K |
|
4730
Trevi Therapeutics
TRVI
$2.57B
| $107K | ﹤0.01% |
36,000
| – | – |
|
4731
Titan International
TWI
$493M
| $107K | ﹤0.01% |
+14,418
| New | +$137K |
|
|
GLO
4732
Clough Global Opportunities Fund
GLO
$243M
| $105K | ﹤0.01% |
19,480
+3,877
| +25% | +$19.7K |
|
4733
Oramed Pharmaceuticals
ORMP
$162M
| $104K | ﹤0.01% |
40,471
-5,130
| -11% | -$12.2K |
|
|
SRTA
4734
Strata Critical Medical Inc
SRTA
$422M
| $104K | ﹤0.01% |
29,783
-297
| -1% | -$991 |
|
|
CCIF
4735
Carlyle Credit Income Fund
CCIF
$57.2M
| $103K | ﹤0.01% |
12,622
+1,732
| +16% | +$14K |
|
|
NAGE
4736
Niagen Bioscience
NAGE
$257M
| $103K | ﹤0.01% |
37,791
| – | – |
|
4737
Lexicon Pharmaceuticals
LXRX
$1.03B
| $103K | ﹤0.01% |
61,085
-28,878
| -32% | -$51.8K |
|
4738
Aurora
AUR
$11.7B
| $102K | ﹤0.01% |
36,947
+10,061
| +37% | +$27.8K |
|
4739
C4 Therapeutics
CCCC
$388M
| $102K | ﹤0.01% |
+22,100
| New | +$132K |
|
4740
Seres Therapeutics
MCRB
$45.3M
| $102K | ﹤0.01% |
7,031
+542
| +8% | +$9.04K |
|
|
SLI
4741
Standard Lithium
SLI
$475M
| $101K | ﹤0.01% |
81,047
+12,325
| +18% | +$17.1K |
|
4742
Medallion Financial
MFIN
$229M
| $101K | ﹤0.01% |
13,175
-500
| -4% | -$3.96K |
|
4743
IAMGOLD
IAG
$8.04B
| $101K | ﹤0.01% |
+26,919
| New | +$103K |
|
|
BRKL
4744
DELISTED
Brookline Bancorp
BRKL
| $100K | ﹤0.01% |
+12,009
| New | +$105K |
|
4745
Enel Chile
ENIC
$6.02B
| $100K | ﹤0.01% |
35,793
-5,940
| -14% | -$17.6K |
|
|
FOLD
4746
DELISTED
Amicus Therapeutics
FOLD
| $100K | ﹤0.01% |
+10,096
| New | +$104K |
|
4747
Ring Energy
REI
$307M
| $98.9K | ﹤0.01% |
58,538
+3,838
| +7% | +$7.06K |
|
4748
DarioHealth
DRIO
$52M
| $98.5K | ﹤0.01% |
4,140
-505
| -11% | -$14.3K |
|
4749
Matinas BioPharma
MTNB
$1.86M
| $96.9K | ﹤0.01% |
12,247
| – | – |
|
|
CIF
4750
DELISTED
MFS Intermediate High Income Fund
CIF
| $96.7K | ﹤0.01% |
57,050
-5,630
| -9% | -$9.49K |
|
Similar funds
LPL Financial's Q2 2024 Portfolio in Review
As of Q2 2024, LPL Financial held 5,204 positions worth $201B, up 7.8% from $186B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
LPL Financial deployed $11.6B of net new capital in Q2 2024, opening 296 new positions and adding to 3,022 existing holdings. Its largest new stake was AB Short Duration High Yield ETF: 1,874,937 shares worth $65.8M.
By sector, the portfolio is most concentrated in Technology at 8.1% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares MSCI EAFE Value ETF, an estimated $124M trimmed.
- LPL Financial's largest Q2 2024 buy was AB Short Duration High Yield ETF: 1,874,937 shares worth $65.8M.
- LPL Financial added most to iShares S&P 500 Growth ETF in Q2 2024, an estimated $346M increase.
- LPL Financial's biggest Q2 2024 reduction was iShares MSCI EAFE Value ETF, cutting an estimated $124M.
- LPL Financial fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $30.9M.
- LPL Financial's ten largest holdings make up 17% of its $201B portfolio in Q2 2024.
- LPL Financial opened 296 new positions and closed 196 in Q2 2024.
- LPL Financial's portfolio value rose 7.8% quarter-over-quarter to $201B.
Based on LPL Financial's 13F filing for Q2 2024, filed 7 Aug 2024.